Evaluation of different inactivation methods for high and low pathogenic avian influenza viruses in egg-fluids for antigen preparation

Journal of Virological Methods

Volumn 222, Issue , 2015, Pages 28-33

  Pawar, Shailesh D ^a   Murtadak, Vinay B ^a   Kale, Sandeep D ^a   Shinde, Prashant V ^a   Parkhi, Saurabh S ^a  

^a NATIONAL INSTITUTE OF VIROLOGY   (India)

Author keywords

Avian influenza; BPL; Ether; Formalin; Inactivation

Indexed keywords

ETHER; FORMALDEHYDE; POLYSORBATE 20; PROPIOLACTONE; VIRUS ANTIGEN; ANTIGEN; DISINFECTANT AGENT; INFLUENZA VIRUS HEMAGGLUTININ;

ANTIGENICITY; ARTICLE; AVIAN INFLUENZA VIRUS; CONTROLLED STUDY; EGG; GENOTYPE; INFLUENZA VIRUS A H11N1; INFLUENZA VIRUS A H4N6; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H9N2; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; VIRUS HEMAGGLUTINATION; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS VIRULENCE; ANIMAL; AVIAN INFLUENZA; CHICK EMBRYO; CHICKEN; DISINFECTION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; INFLUENZA A VIRUS; ISOLATION AND PURIFICATION; MICROBIAL VIABILITY; PHYSIOLOGY; PROCEDURES; VIROLOGY;

AVES; AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIGENS; CHICK EMBRYO; CHICKENS; DISINFECTANTS; DISINFECTION; ETHER; FORMALDEHYDE; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; MICROBIAL VIABILITY; PROPIOLACTONE; VIRUS INACTIVATION;

EID: 84930934324     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2015.05.004     Document Type: Article

References (33)

1. Alexander D.J. A review of avian influenza in different bird species. Vet. Microbiol. 2000, 74:3-13.
2. Andrewes C.H., Horstmann D.M. The susceptibility of viruses to ethyl ether. J. Gen. Microbiol. 1949, 2:290-297.
3. Budowsky E.I., Smirnov Y.A., Shenderovich S.F. Principles of selective inactivation of viral genome. VIII. The influence of β-propiolactone on immunogenic and protective activities of influenza virus. Vaccine 1993, 11:343-348.
4. CDC information on avian influenza, 2014. (accessed 29.04.14). http://www.cdc.gov/flu/avianflu/avian-in-humans.htm.
5. Chakrabarti A.K., Pawar S.D., Cherian S.S., Koratkar S.S., Jadhav S.M., Pal B., Raut S., Thite V., Kode S.S., Keng S.S., Payyapilly B.J., Mullick J., Mishra A.C. Characterization of the influenza A H5N1 viruses of the 2008-09 outbreaks in India reveals a third introduction and possible endemicity. PLoS ONE 2009, 4:e7846.
6. Choppin P.W., Stoeckenius W. Interactions of ether-disrupted influenza A2 virus with erythrocytes, inhibitors, and antibodies. Virology 1964, 22:482-492.
7. Chu C.M. Inactivation of haemagglutinin and infectivity of influenza and newcastle disease viruses by heat and by formalin. J. Hyg. (Lond.) 1948, 46:247-251.
8. De Benedictis P., Beato M.S., Capua I. Inactivation of avian influenza viruses by chemical agents and physical conditions: a review. Zoonoses Public Health 2007, 54:51-68.
9. Fenters J.D., Yamashiroya H.M., Petzold R.F., Tolkacz V.K. Enhanced immunogenicity in mice of a purified, tween-ether-treated influenza vaccine. Appl. Microbiol. 1970, 20:544-550.
10. Francis T. Vaccination against influenza. Bull. World Health Organ 1953, 8:725-741.
11. Furuya Y., Regner M., Lobigs M., Koskinen A., Mullbacher A., Alsharifi M. Effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations. J. Gen. Virol. 2010, 91:1450-1460.
12. Goldstein M.A., Tauraso N.M. Effect of formalin, beta-propiolactone, merthiolate, and ultraviolet light upon influenza virus infectivity, chicken cell agglutination, hemagglutination, and antigenicity. Appl. Microbiol. 1970, 19:290.
13. Jonges M., Liu W.M., van der Vries E., Jacobi R., Pronk I., Boog C., Koopmans M., Meijer A., Soethout E. Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling. J. Clin. Microbiol. 2010, 48:928-940.
14. Kawaoka Y., Chambers T.M., Sladen W.L., Webster R.G. Is the gene pool of influenza viruses in shorebirds and gulls different from that in wild ducks?. Virology 1988, 163:247-250.
15. Kendal A.P., Cate T.R. Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79. J. Clin. Microbiol. 1983, 18:930-934.
16. King D.J. Evaluation of different methods of inactivation of Newcastle disease virus and avian influenza virus in egg fluids and serum. Avian Dis. 1991, 35:505-514.
17. Knipe D.M., Howley P.M. Fields Virology 2007, vol. 1. Lippincott Williams and Wilkins, Philadelphia, EUA.
18. Monto A.S., Maassab H.F. Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test. J. Clin. Microbiol. 1981, 13:54-57.
19. Muhmmad K.P., Das P., Yaqoob T., Riaz R., Manzooret Effect of physico-chemical factors on survival of avian influenza virus (H7N3 type). Int. J. Agric. Biol. 2001, 4:416-418.
20. Nagarajan S., Murugkar H.V., Tosh C., Behera P., Jain R., Tripathi S., Khandia R., Gupta V., Kulkarni D.D., Dubey S.C. Avian influenza virus (H5N1) in chickens in India. Vet. Rec. 2009, 164:128.
21. Oie update on avian influenza, 2014. (accessed 29.04.14). http://www.oie.int/animal-health-in-the-world/update-on-avian-influenza.
22. Pawar S.D., Parkhi S.S., Koratkar S.S., Mishra A.C. Receptor specificity and erythrocyte binding preferences of avian influenza viruses isolated from India. Virol. J. 2012, 9:251.
23. Pawar S.D., Kale S.D., Rawankar A.S., Koratkar S.S., Raut C.G., Pande S.A., Mullick J., Mishra A.C. Avian influenza surveillance reveals presence of low pathogenic avian influenza viruses in poultry during 2009-2011 in the West Bengal State, India. Virol. J. 2012, 9:151.
24. Perrin P., Morgeaux S. Inactivation of DNA by beta-propiolactone. Biologicals 1995, 23:207-211.
25. Reed L.J., Muench H.A. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 1938, 27:493-497.
26. Shahid M.A., Abubakar M., Hameed S., Hassan S. Avian influenza virus (H5N1); effects of physico-chemical factors on its survival. Virol. J. 2009, 6:38.
27. Swayne D.E., Kapczynski D.R. Vaccines, vaccination, and immunology for avian influenza viruses in poultry. Avian Influenza 2008, 407-452. Blackwell Publishing, Oxford; USA. D.E. Swayne (Ed.).
28. Takada A., Matsushita S., Ninomiya A., Kawaoka Y., Kida H. Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 2003, 21:3212-3218.
29. Tong S., Li Y., Rivailler P., et al. A distinct lineage of influenza A virus from bats. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:4269-4274.
30. Tong S., Zhu X., Li Y., et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013, 9:e1003657.
31. WHO Manual on Animal Influenza Diagnosis and Surveillance. WHO/CDS/CSR/NCS 2002, 5:15-62. WHO, Geneva, Switzerland.
32. WHO Recommendations for Production and Control of Influenza Vaccine (inactivated) 2003, WHO, Geneva, Switzerland.
33. Zou S., Guo J., Gao R., Dong L., Zhou J., Zhang Y., Dong J., Bo H., Qin K., Shu Y. Inactivation of the novel influenza A (H7N9) virus under physical conditions or chemical agents treatment. Virol. J. 2013, 10:289.